Gsk Cash Flow Statement (2009-2026) | GSK

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	0.37B	0.58B	2.13B	0.53B	0.29B	11.88B	0.73B	2.32B	2.49B	2.27B	4.83B	1.72B	1.89B	0.08B	3.66B	2.66B	2.52B	3.31B	1.26B	2.89B
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)			-0.16B	-0.06B			-0.07B	-0.07B			-0.07B	-0.02B			-0.06B	-0.03B			-0.05B	-0.01B
Asset Writedowns and Impairment (Quarter)
Change in Working Capital (Quarter)		-1.66B	-1.09B			-0.79B	-0.23B			-3.38B
Cash from Operations (Quarter)	1.81B	3.53B	2.19B	3.70B			2.87B	0.35B	1.64B	2.80B	3.97B	1.43B	1.40B	2.80B	2.99B	1.64B	2.80B	3.00B	3.03B	1.82B
Depreciation, Depletion & Amortization
Amortization (Quarter)	2.15B	1.89B	6.87B	14.43B	1.23B	12.80B	18.32B	3.31B	2.18B	1.94B	6.59B	1.37B	1.65B	0.08B	3.79B	2.23B	20.51B	2.89B	8.37B	4.31B
Change in Working Capital
Change in Accured Expenses (Quarter)
Other Working Capital Changes (Quarter)				-0.90B
Investing Activities
Capital Expenditures (Quarter)	-0.33B	-0.38B	-1.28B	-0.26B		-0.32B	3.23B	-0.28B	-0.37B	-0.38B	-1.63B	-0.31B	-0.38B	-0.40B	-0.70B	-0.26B	-0.34B	-0.42B	-0.76B	-0.30B
Sales of Property, Plant and Equipment (Quarter)	0.09B	0.03B	0.13B	0.01B			0.01B	0.01B	0.00B	0.01B	0.01B	0.00B	0.00B	0.00B	0.08B	0.00B	0.01B	0.01B	0.02B	0.04B
Change in Intangibles (Quarter)	-0.59B	-1.39B	-2.30B	-0.51B		-0.24B	-1.31B	-0.36B	-0.30B	-0.25B	-0.37B	-0.40B	-0.18B	-0.70B	-2.03B	-0.30B	-0.50B	-0.77B	-0.60B	-0.30B
Acquisitions (Quarter)							-0.09B				-1.74B	-0.91B			-0.96B	-1.01B			-0.05B	-1.89B
Divestments (Quarter)			0.23B				-0.19B	0.01B			1.00B	1.34B			-3.04B				-0.22B	0.00B
Cash from Investing Activities (Quarter)			-0.31B	-4.82B			-4.85B	-0.50B			-1.70B	-0.19B			0.80B	-1.44B			-1.24B	-1.98B
Financing Activities
Other financing activities (Quarter)	-0.04B	-0.04B	0.01B	0.01B		-0.00B	0.42B	0.01B	-0.00B	-0.00B	0.41B	0.05B	0.00B	0.01B	-0.01B	-0.04B	-0.00B	-0.01B	-0.02B	2.14B
Cash from Financing Activities (Quarter)			4.31B	10.70B			4.09B	-0.39B			-0.36B	-1.34B			-3.39B	1.08B			-1.14B	0.37B
Dividend Payments
Dividends Paid - Common (Quarter)	-0.12B	-0.16B	-0.32B	-1.28B		-0.25B	6.04B	-0.67B	-0.17B	-0.07B	-0.51B	-0.72B	-0.14B	-0.10B	-0.16B	-0.77B	-0.16B	-0.13B	-0.52B	-0.87B
Additional items
Exchange Rate Effect (Quarter)			-0.05B	0.02B			0.10B	-0.04B			-0.11B	-0.02B			-0.03B	-0.01B			-0.05B	0.00B
Change in Cash (Quarter)
Free Cash Flow (Quarter)	2.14B	3.92B	3.47B	3.96B		0.32B	-0.36B	0.63B	2.01B	3.18B	5.60B	1.74B	1.79B	3.19B	3.69B	1.90B	3.14B	3.42B	3.79B	2.12B
Net Cash Flow (Quarter)	1.81B	3.53B	6.18B	9.57B			2.11B	-0.53B	1.64B	2.80B	1.91B	-0.11B	1.40B	2.80B	0.39B	1.28B	2.80B	3.00B	0.65B	0.21B

Research Tools

Gsk Cash Flow Statement (2009-2026) | GSK

Create an account

Sign In

Reset Password